Glycolipids and analogues thereof as antigens for NKT cells
US7923013B2 · kind B2 · utility
34Cited by
5References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 13, 2007 |
| Grant date | Apr 12, 2011 |
| Priority date | — |
| Expiry date | Jun 12, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.